Pulmonary Hypertension Trial, Recruiting (NCT07254338)

Pulmonary Hypertension Trial, Recruiting NCT07254338 Sponsor: Hospices Civils de Lyon Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07254338 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a progressive lung disease where the lung tissue becomes scarred or stiff over time (called interstitial lung disease or lung fibrosis)
Your doctor suspects you may also have high blood pressure in the arteries of your lungs, linked to your lung disease (confirm with trial site)
You are already scheduled to have a heart catheter procedure to check the blood pressure and blood flow in your heart and lungs
You have been fully informed about the trial and have agreed to take part

Who may not be able to join:

You have a different type of high blood pressure in the lung arteries that is not related to lung disease — for example, a type called PAH, CTEPH, high blood pressure caused by heart failure, or a mixed/unclear cause (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 72 35 73 32

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07254338

Sponsor: Hospices Civils de Lyon

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 04 72 35 73 32

More information: https://clinicaltrials.gov/study/NCT07254338

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a progressive lung disease where the lung tissue becomes scarred or stiff over time (called interstitial lung disease or lung fibrosis)
Your doctor suspects you may also have high blood pressure in the arteries of your lungs, linked to your lung disease (confirm with trial site)
You are already scheduled to have a heart catheter procedure to check the blood pressure and blood flow in your heart and lungs
You have been fully informed about the trial and have agreed to take part

Who may not be able to join:

You have a different type of high blood pressure in the lung arteries that is not related to lung disease — for example, a type called PAH, CTEPH, high blood pressure caused by heart failure, or a mixed/unclear cause (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospices Civils de Lyon

Registry

ClinicalTrials.gov

Start date

16 February 2026

Est. completion

16 August 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of urinary metabolite concentrations before and after initiation of treatment measured centrally by proton nuclear magnetic resonance spectroscopy (¹H-NMR).; Comparison of blood metabolite concentrations before and after initiation of treatment measured centrally by proton nuclear magnetic resonance spectroscopy (¹H-NMR).; Comparative prognosis analysis within sub-groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov